학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 779건 | 목록 1~10
Academic Journal
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Peters FS; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Mes M; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Rietveld JM; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Cerretani E; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Cretenet G; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; van Kampen R; Zuyderland Medical Center, Sittard-Geleen, The Netherlands.; Jongejan A; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Moerland PD; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Melenhorst JJ; Cleveland Clinic, Lerner Research Institute, Center for Immunotherapy & Precision Immuno-Oncology, Cleveland, OH.; van der Windt GJW; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Eldering E; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Simon-Molas H; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, the Netherlands; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Montironi C; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Kabanova A; Tumour Immunology Unit, Toscana Life Sciences Foundation, Siena, Italy.; Eldering E; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: E.Eldering@amsterdamumc.nl.
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0404514 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8686 (Electronic) Linking ISSN: 00371963 NLM ISO Abbreviation: Semin Hematol Subsets: MEDLINE
Academic Journal
Montironi C; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Jacobs CF; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cretenet G; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Peters FS; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Schomakers BV; Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Core Facility Metabolomics, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; van Weeghel M; Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Core Facility Metabolomics, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Kater AP; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Simon-Molas H; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Eldering E; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Cancer Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Martens AWJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.; Rietveld JM; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; de Boer R; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Peters FS; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.; Ngo A; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; van Mil LWHG; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; de Heer K; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Hematology, Flevoziekenhuis, Almere, the Netherlands.; Spaargaren M; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Pathology, University of Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands.; Verkleij CPM; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; van de Donk NWCJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Adams HC 3rd; Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania.; Eldering E; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands.; van Noesel CJM; Department of Pathology, University of Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands.; Verona R; Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania.; Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun
Academic Journal
Fürstenau M; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Thus YJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Robrecht S; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Mellink CHM; Genome Diagnostics Laboratory, Section Cytogenetics, Department of Human Genetics, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; van der Kevie-Kersemaekers AM; Genome Diagnostics Laboratory, Section Cytogenetics, Department of Human Genetics, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Dubois J; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; von Tresckow J; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Patz M; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.; Swiss Group for Clinical Cancer Research, Berne, Switzerland.; Thornton P; Department of Haematology, Beaumont Hospital, RCSI University of Medicine and Health Sciences, Cancer Trials Ireland, Dublin, Ireland.; Staber PB; Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Tadmor T; Hematology, Bnai-Zion Medical Center, Haifa, Israel.; Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Schneider C; Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Poulsen CB; Department of Hematology, Zealand University Hospital, Roskilde, Roskilde, Denmark.; Illmer T; BAG Freiberg-Richter, Jacobasch, Wolf, Illmer, Dresden, Germany.; Schöttker B; Hämatologisch-onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany.; Janssens A; Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.; Christiansen I; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.; Nösslinger T; Department of Internal Medicine III, Hanusch Hospital, Vienna, Austria.; Baumann M; Swiss Group for Clinical Cancer Research, Berne, Switzerland.; Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Hebart H; Department of Oncology, Stauferklinikum, Mutlangen, Germany.; Gaska T; Hematology and Oncology, Brüderkrankenhaus, Paderborn, Germany.; Regelink JC; Department of Haematology, Meander Medisch Centrum, Amersfoort, The Netherlands.; Dompeling EC; Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands.; Lindström V; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Juliusson G; Department of Hematology, Skåne University Hospital, Lund, Sweden.; Widmer A; Swiss Group for Clinical Cancer Research, Berne, Switzerland.; Department of Medical Oncology and Haematology, Universitätsspital Zürich, Zürich, Switzerland.; Goede J; Swiss Group for Clinical Cancer Research, Berne, Switzerland.; Clinic for Medical Oncology and Hematology, Cantonal Hospital of Winterthur, Winterthur, Switzerland.; Goldschmidt N; Department of Hematology, Hadassah Medical Center, Jerusalem, Israel.; Simon F; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; De Silva N; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Fink AM; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Fischer K; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Wendtner CM; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, German CLL Study Group, Munich Clinic Schwabing, Munich, Germany.; Ritgen M; Department II of Internal Medicine, University of Schleswig-Holstein, Kiel, Germany.; Brüggemann M; Department II of Internal Medicine, University of Schleswig-Holstein, Kiel, Germany.; Tausch E; Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Spaargaren M; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Eldering E; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Stilgenbauer S; Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Hallek M; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Eichhorst B; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Kreuzer KA; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany.; Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Eldering, B.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어